311 related articles for article (PubMed ID: 9557710)
1. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.
Jooss K; Yang Y; Fisher KJ; Wilson JM
J Virol; 1998 May; 72(5):4212-23. PubMed ID: 9557710
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.
Zhang Y; Chirmule N; Gao Gp; Wilson J
J Virol; 2000 Sep; 74(17):8003-10. PubMed ID: 10933709
[TBL] [Abstract][Full Text] [Related]
3. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
[TBL] [Abstract][Full Text] [Related]
4. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
Yang Y; Haecker SE; Su Q; Wilson JM
Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
[TBL] [Abstract][Full Text] [Related]
5. AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells.
Somanathan S; Breous E; Bell P; Wilson JM
Mol Ther; 2010 May; 18(5):977-82. PubMed ID: 20234342
[TBL] [Abstract][Full Text] [Related]
6. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.
Mercier S; Gahéry-Segard H; Monteil M; Lengagne R; Guillet JG; Eloit M; Denesvre C
J Virol; 2002 Mar; 76(6):2899-911. PubMed ID: 11861857
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles.
Aubert D; Pichard V; Durand S; Moullier P; Ferry N
Hum Gene Ther; 2003 Mar; 14(5):473-81. PubMed ID: 12691612
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins.
Mays LE; Vandenberghe LH; Xiao R; Bell P; Nam HJ; Agbandje-McKenna M; Wilson JM
J Immunol; 2009 May; 182(10):6051-60. PubMed ID: 19414756
[TBL] [Abstract][Full Text] [Related]
10. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.
Sarukhan A; Soudais C; Danos O; Jooss K
J Gene Med; 2001; 3(3):260-70. PubMed ID: 11437331
[TBL] [Abstract][Full Text] [Related]
12. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.
Xin KQ; Mizukami H; Urabe M; Toda Y; Shinoda K; Yoshida A; Oomura K; Kojima Y; Ichino M; Klinman D; Ozawa K; Okuda K
J Virol; 2006 Dec; 80(24):11899-910. PubMed ID: 17005662
[TBL] [Abstract][Full Text] [Related]
13. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
[TBL] [Abstract][Full Text] [Related]
14. AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells.
Mays LE; Wang L; Lin J; Bell P; Crawford A; Wherry EJ; Wilson JM
Mol Ther; 2014 Jan; 22(1):28-41. PubMed ID: 23778424
[TBL] [Abstract][Full Text] [Related]
15. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.
Lu Y; Song S
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176
[TBL] [Abstract][Full Text] [Related]
16. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.
Muhuri M; Zhan W; Maeda Y; Li J; Lotun A; Chen J; Sylvia K; Dasgupta I; Arjomandnejad M; Nixon T; Keeler AM; Manokaran S; He R; Su Q; Tai PWL; Gao G
Front Immunol; 2021; 12():674242. PubMed ID: 33995418
[TBL] [Abstract][Full Text] [Related]
17. Effect of CpG Depletion of Vector Genome on CD8
Bertolini TB; Shirley JL; Zolotukhin I; Li X; Kaisho T; Xiao W; Kumar SRP; Herzog RW
Front Immunol; 2021; 12():672449. PubMed ID: 34135899
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity.
Martino AT; Nayak S; Hoffman BE; Cooper M; Liao G; Markusic DM; Byrne BJ; Terhorst C; Herzog RW
PLoS One; 2009 Aug; 4(8):e6376. PubMed ID: 19652717
[TBL] [Abstract][Full Text] [Related]
19. The complex and evolving story of T cell activation to AAV vector-encoded transgene products.
Mays LE; Wilson JM
Mol Ther; 2011 Jan; 19(1):16-27. PubMed ID: 21119617
[TBL] [Abstract][Full Text] [Related]
20. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]